Continuous Femoral Block With Levobupivacaine 0.125% or Ropivacaine 0.2% in Elderly Patients With Femoral Fractures
Clinical trial NCT03815565 · UNKNOWN
Trial details
- NCT number
- NCT03815565
- Sponsor
- Hospital Municipal Miguel Couto
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-28
- Primary completion
- 2020-08-08
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.